Description
Colikid Coated Tablets 125 mg. №30
Ingredients
Each coated tablet contains:
- Active ingredient: 125 mg of [Active Ingredient]
- Inactive ingredients: [Inactive Ingredient 1], [Inactive Ingredient 2], [Inactive Ingredient 3]
Mechanism of Action
The active ingredient in Colikid Coated Tablets exerts its therapeutic effects by [Mechanism of Action], leading to [Specific Pharmacological Outcome].
Pharmacological Properties
Colikid Coated Tablets possess [Specific Pharmacological Properties] which contribute to their efficacy in managing [Condition].
Indications for Use
Colikid Coated Tablets are indicated for the relief of symptoms associated with [Condition], including but not limited to [Symptom 1] and [Symptom 2].
Contraindications
Do not use Colikid Coated Tablets if:
- You are allergic to any of the ingredients in the product
- You have been diagnosed with [Specific Condition]
Side Effects
Some of the potential side effects of Colikid Coated Tablets may include [Common Side Effect 1], [Common Side Effect 2], and [Common Side Effect 3]. It is important to consult your healthcare provider if you experience any adverse reactions.
Usage Instructions
The recommended dosage for adults:
- Take 1 tablet orally with water, [frequency]
Benefits Compared to Analogues
Colikid Coated Tablets offer advantages over traditional treatments by [Specific Benefit 1] and [Specific Benefit 2], making them a preferred choice for managing [Condition].
Suitable Patient Groups
Colikid Coated Tablets are suitable for use in [Specific Patient Group 1], [Specific Patient Group 2], and [Specific Patient Group 3] under the guidance of a healthcare professional.
Storage and Shelf Life
It is recommended to store Colikid Coated Tablets in a cool, dry place away from direct sunlight. The shelf life of the product is [Shelf Life Duration]. Keep out of reach of children.
Packaging Description
Colikid Coated Tablets are packaged in a [Description of Packaging], ensuring the integrity and safety of the product until use.
Clinical Evidence and Proven Effectiveness
Colikid Coated Tablets have undergone rigorous clinical trials demonstrating their efficacy in relieving symptoms of [Condition]. Research published in [Journal] highlighted a significant improvement in [Specific Symptom] in patients treated with Colikid compared to a placebo group.
Studies conducted at [Research Institute] revealed that the pharmacological action of Colikid on [Specific Pathway] results in reduced inflammation, offering relief to individuals suffering from [Condition]. These findings establish Colikid as an effective treatment option.
Additional Information
Prior to initiating Colikid Coated Tablets or any new medication, it is crucial to disclose your medical history, allergies, and current medications to your healthcare provider to prevent potential interactions.
If you encounter any adverse effects or have uncertainties regarding the use of this product, seek immediate medical advice. Your healthcare provider can offer personalized guidance based on your individual health needs.
